Natural Killer Cells in Kidney Transplantation: Dual Role in Allograft Injury and Immune Adaptation
Archivum Immunologiae et Therapiae Experimentalis · 2026
DOI: 10.2478/aite-2026-0026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, 2026. Verfasst von Anna Skotny und 6 weiteren Autor:innen. Beteiligte Einrichtung: Harvard T.H. Chan School of Public Health-Executive and Continuing Education, Harvard University, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Killer Cells, Natural, Graft Rejection. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kidney transplantation is the optimal treatment for end-stage renal disease, yet long-term graft survival remains limited by allograft rejection. While T and B cells and donor-specific antibodies (DSA) have been the main focus, accumulating evidence indicates that natural killer (NK) cells play a significant dual role in both graft injury and immune adaptation, including in DSA-negative rejection. This narrative review summarizes current knowledge on the dual role of NK cells in kidney transplantation, with emphasis on antibody-independent mechanisms, adaptive NK-cell subsets, and their potential as biomarkers of graft outcome. NK cells are highly heterogeneous, consisting of CD56 bright and CD56 dim CD16 subsets. Cytomegalovirus infection promotes expansion of adaptive NKG2C + CD57 + cells with memory-like features. In rejection, NK cells act through both antibody-dependent cellular cytotoxicity and antibody-inde-pendent pathways, such as “missing-self” recognition via killer immunoglobulin-like receptors (KIR)/human leukocyte antigen (HLA) mismatch and release of the killer-specific secretory protein of 37 kDa (Ksp37). Specific NK subsets are associated with microvascular inflammation and graft loss even in the absence of DSA. In contrast, NK cells support tolerance by killing donor dendritic cells and activated T cells, producing interleukin (IL)-10 and transforming growth factor-β (TGF-β), and undergoing reeducation, gradually shifting from a cytotoxic to a regulatory phenotype. NK cells exert a dual, often opposing role in kidney transplantation, mediating both allograft injury and immune tolerance. Better understanding of their plasticity may enable new biomarkers and NK-targeted therapies to improve long-term graft survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harvard T.H. Chan School of Public Health-Executive and Continuing Education, Harvard University, Boston, MA 02115, USA.
- Clinical Research Support Center, 4th Military Hospital, Wrocław, Poland.
- Division of Nephrology, Transplantology, and Clinical Immunology at 4th Military Clinical Hospital, Department of Non-Procedural Clinical Sciences, Faculty of Medicine, Wroclaw University of Science and Technology, Wroc…
ORCID-Profile: Anna Skotny, Paweł Poznański, Katarzyna Kościelska-Kasprzak, Dorota Bartoszek, Marcelina Żabińska, Dorota Kamińska, Magdalena Krajewska
Zitieren
APA
Skotny, A., Poznański, P., Kościelska-Kasprzak, K., Bartoszek, D., Żabińska, M., Kamińska, D., & Krajewska, M. (2026). Natural Killer Cells in Kidney Transplantation: Dual Role in Allograft Injury and Immune Adaptation. Archivum Immunologiae et Therapiae Experimentalis. https://doi.org/10.2478/aite-2026-0026
Vancouver
Skotny A, Poznański P, Kościelska-Kasprzak K, Bartoszek D, Żabińska M, Kamińska D, et al. Natural Killer Cells in Kidney Transplantation: Dual Role in Allograft Injury and Immune Adaptation. Archivum Immunologiae et Therapiae Experimentalis. 2026. doi:10.2478/aite-2026-0026
BibTeX
@article{Skotny2026,
author = {Skotny, Anna and Poznański, Paweł and Kościelska-Kasprzak, Katarzyna and Bartoszek, Dorota and Żabińska, Marcelina and Kamińska, Dorota and Krajewska, Magdalena},
title = {Natural Killer Cells in Kidney Transplantation: Dual Role in Allograft Injury and Immune Adaptation},
journal = {Archivum Immunologiae et Therapiae Experimentalis},
year = {2026},
doi = {10.2478/aite-2026-0026}
}
EUVIMED